Eradicating cervical cancer in Thailand: A journey of hope and progress

Overview

Thailand has made significant progress in cervical cancer control and is on track to achieve the 90-70-90 targets by 2030, particularly through HPV vaccination and screening programs. The HPV vaccine has been included in the national immunization schedule since 2017 and is offered free of charge to girls aged 11–12. However, challenges remain in reaching 90% coverage, including issues with vaccine supply, logistical barriers, and regional disparities. Cervical cancer screening has transitioned from cytology to HPV-based methods since 2020, with self-collection options introduced in 2023 for women aged 30–60. The Cancer Anywhere program, launched in 2021, aims to provide timely cancer care. Nevertheless, challenges persist, especially in rural areas, where personal knowledge, attitudes, and socioeconomic factors continue to be barriers despite universal health coverage across public hospitals. Advanced-stage diagnoses are common among underserved populations. To improve outcomes, Thailand is focusing on population education, expanding oncology services, investing in workforce development, strengthening referral networks, and promoting the best clinical practices through standardized treatment protocols.